Abstract
We compared the effectiveness of antibiotic postprescription review and authorization (PPRA) determined by infectious disease (ID) clinical fellows with that of trained general pharmacists. We conducted a noninferiority cluster-randomized controlled trial in 6 general medical wards at Siriraj Hospital in Bangkok, Thailand. Three wards were randomly assigned to the intervention (ie, the pharmacist PPRA group), and another 3 wards were assigned to the control (ie, the fellow PPRA group). We enrolled all patients in the study wards who received 1 or more doses of the targeted antibiotics: piperacillin/tazobactam, imipenem/cilastatin, and meropenem. The noninferiority margin was 10% for the favorable clinical response and 1.5 defined daily doses (DDDs) for the targeted antibiotics. We enrolled 303 patients in the pharmacist PPRA group and 307 patients in the ID fellow PPRA group. The baseline and clinical characteristics were similar in the 2 groups. The difference in the favorable response of patients who received the targeted antibiotics (ie, the pharmacist PPRA group minus the fellow PPRA group) was 5.15% (95% confidence interval [CI], -2.69% to 12.98%); the difference in the DDD of targeted antibiotic use (ie, the pharmacist PP...Continue Reading
References
Jul 5, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R GrossN O Fishman
Jun 5, 2002·Annals of Internal Medicine·Nasia Safdar, Dennis G Maki
Oct 9, 2003·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Sujata M BhavnaniJerome J Schentag
Feb 24, 2006·Emerging Infectious Diseases·Peter DaveyMark Wilcox
Mar 18, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert C Owens, Louis Rice
Dec 19, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Timothy H DellitUNKNOWN Society for Healthcare Epidemiology of America
Jul 28, 2007·European Journal of Haematology·Leon J WorthMonica A Slavin
Aug 19, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Louis ValiquetteJacques Pépin
Oct 24, 2007·Pharmacotherapy·Michael J Rybak
Apr 3, 2008·Expert Review of Anti-infective Therapy·Dimple PatelB Joseph Guglielmo
Nov 11, 2008·Diagnostic Microbiology and Infectious Disease·Min-Hyok JeonYang Soo Kim
Aug 25, 2009·American Journal of Infection Control·Pinyo RattanaumpawanVisanu Thamlikitkul
Mar 16, 2012·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Julia MoodyKavita K Trivedi
Mar 8, 2016·The Lancet Infectious Diseases·Emelie C SchutsJan M Prins
Apr 16, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Tamar F BarlamKavita K Trivedi